ARMISTICE CAPITAL, LLC
NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$2.98B2026 Q3+ $5.18B options (notional, not included)
Positions346
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.64.4%
What Changed This Quarter?
Top Holdings
SPYCALL
SPDR S&P 500
31.3%
IWMCALL
Ishares Tr
22.5%
CYTKCALL
Cytokinetics
2.1%
MDGLCALL
Madrigal Pharmaceuticals
1.6%
AGIOCALL
Agios Pharmaceuticals
1.3%
SUPN
Supernus
1.3%
PTCTCALL
PTC Therapeutics
1.3%
AGIO
Agios Pharmaceuticals
1.1%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.